McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis

McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis

McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis

McKinsey & Company, the consultant to blue-chip corporations and governments around the world, has agreed to pay nearly $600 million to settle investigations into its role in helping “turbocharge” opioid sales, a rare instance of it being held publicly accountable for its work with clients.

The firm has reached a $573 million agreement with attorneys general in 47 states, the District of Columbia and five territories, according to a court filing in Massachusetts on Thursday. Separate deals were announced in Washington State, for $13 million, and in West Virginia, for $10 million. Nevada, not party to the agreements, will continue to pursue its opioid investigation, according to the attorney general’s office.

The settlements come after lawsuits unearthed a trove of documents showing how McKinsey worked to drive sales of Purdue Pharma’s OxyContin painkiller amid an opioid crisis in the United States that has contributed to the deaths of more than 450,000 people over the past two decades.


About TriMark

TriMark Legal Funding provides non-recourse pre settlement lawsuit funding and post settlement loans to injured plaintiffs nationwide. Call (877) 932-2628 with questions or to apply for funding.

This post originally appeared here: https://www.nytimes.com/2021/02/03/business/mckinsey-opioids-settlement.html

Click here to see the full original article.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408